Article

AMO offers new ultrasound technology for phaco system

Santa Ana, CA?Abbott Medical Optics (AMO) announced that enhanced ultrasound technology (Ellips FX Transversal Ultrasound Technology) is available for its phacoemulsification system (WhiteStar Signature).

Santa Ana, CA

- Abbott Medical Optics (AMO) announced that enhanced ultrasound technology (Ellips FX Transversal Ultrasound Technology) is available for its phacoemulsification system (WhiteStar Signature).

Refined features over the company’s original ultrasound technology (Ellips) include higher frequency cutting performance; larger zone of tissue removal; improved efficiency for removal of hard or soft cataracts, working with preferred cataract surgery technique or tip style; and controlled utilization of power required for lens extraction, as well as unique movement of the tip minimizing the potential for clogging and contributing to overall stability of the chamber.

AMO said it has begun shipping the new ultrasound technology to surgeons throughout the United States.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.